Stonebridge Capital Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15
Closed -$2K 1021
2021
Q3
$2K Sell
15
-15
-50% -$2.3K ﹤0.01% 834
2021
Q2
$4K Buy
30
+15
+100% +$2.09K ﹤0.01% 861
2021
Q1
$2K Buy
+15
New +$1.92K ﹤0.01% 848
2020
Q3
Sell
-15
Closed -$1K 539
2020
Q2
$1K Sell
15
-13
-46% -$890 ﹤0.01% 734
2020
Q1
$2K Buy
+28
New +$2.23K ﹤0.01% 655

Other funds holding OMCL

Stonebridge Capital Advisors's OMCL Position: Q4 2021 in Review

Stonebridge Capital Advisors sold out of Omnicell (OMCL) in Q4 2021, closing a stake of 15 shares — an estimated $2K sold.

Stonebridge Capital Advisors first reported a position in OMCL in Q1 2020 and held it in 5 quarters. The position peaked at $4K in Q2 2021. 422 funds tracked by Wall St. Rank hold OMCL as of Q4 2021.

  • Stonebridge Capital Advisors reported no remaining Omnicell position as of Q4 2021 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 15 Omnicell shares in Q4 2021, an estimated $2K.
  • Stonebridge Capital Advisors first reported a position in Omnicell in Q1 2020 and held it in 5 quarters.
  • Stonebridge Capital Advisors's Omnicell position peaked at $4K in Q2 2021.
  • 422 funds tracked by Wall St. Rank held Omnicell as of Q4 2021.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.